Last reviewed · How we verify
Immunogenicity of a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine in Thai Children
The objective of this study is to measured the Geometric mean titer (GMT) of Japanese Encephalitis neutralizing antibody and proportion of seroprotection among the children who received a booster dose of JE-CV after the first dose of SA14-14-2 vaccine.
Details
| Lead sponsor | Chulalongkorn University |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 50 |
| Start date | 2013-12 |
| Completion | 2015-07 |
Conditions
- Japanese Encephalitis
Interventions
- a live attenuated chimeric JE vaccine
Primary outcomes
- Changing in geometric mean titer of JE neutralizing antibody at day 0 pre-vaccination and day 28 post vaccination. — day 0 pre-vaccination and day 28 post vaccination